Pakistan and China enjoy broad space of cooperation in traditional medicine, say experts
BEIJING: Expert Advisory panel on traditional medicine, the World Health Organization (WHO) and co-director of China and Pakistan cooperation center on traditional Chinese medicine, Prof Liu Xinmin has said that traditional Chinese medicine (TCM) and Yunani Tibb (traditional herbal medicine in Pakistan) enjoy a broad space of collaboration in research and development, management and production.
The international center for chemical and biological sciences (ICCBS), University of Karachi, is internationally influential in the field of natural product chemistry. The recognition of traditional Chinese medicine in Pakistan and even the international community is evident from the successful clinical trial of TCM in Pakistan, and it is also a major booster to promote cooperation in traditional medicine between China and Pakistan, the China Economic Net (CEN) cited Prof Liu Xinmin as saying in an interview.
Pakistan’s herbal medicines have rich resources in the treatment of respiratory and skin diseases, and the products are exported to Central Asia and other countries. Pakistanis are accustomed to taking herbal medicines and are highly receptive to TCM.
“In recent years, the industrial scale and research and development level of TCM have been significantly improved. China’s management experience of high-quality herbal medicine resources can be shared with Pakistan. Pakistan is very active in international and exchange platforms, and Pakistan and China can jointly increase the popularity and influence of traditional medicine in the world,” Prof. Liu Xinmin suggested.
After thousands of years of development, TCM has developed numerous effective treatments for plague. TCM has sustained efficacy in the face of complex and variable viruses, and it is well-suited to cope with the ever-changing COVID-19 virus.
Prof Liu Qingquan, president of Beijing Hospital of TCM introduced that TCM has formed an extremely strict theoretical law, and its rapid accessibility is one of its greatest advantages and characteristics.
According to Mao Zhibing, R&D Director of Juxiechang (Beijing) Pharmaceutical Company, the clinical testing of TCM in Pakistan was carried out with the support of the Chinese and Pakistani governments and top-level research teams. The protocols were approved by the Drug Regulatory Authority of Pakistan, Ethics Committees in Pakistan, etc. – News Agencies
